Page 5 - ஒன்றுபட்டது மாநிலங்களில் தேசிய நிறுவனங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Genkyotex: Disclosure of the Total Number of Voting Rights and Shares Pursuant to Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the French Financial Markets Authority Regulatory News: Genkyotex shares Date (1): 14,083,408 meeting (2): 14,074,165 (1) In accordance with Article 223-111 of the AMF s General Regulation, this number of shares is calculated based on all shares carrying the right to vote, including those stripped of voting rights. (2) Less shares stripped of voting rights. About Genkyotex Genkyotex is the leading biopharmaceutical company in NOX therapies, listed on the Euronext Paris and Euronext Brussels markets. Its unique platform enables the identification of orally available small-molecules which selectively inhibit specific NOX enzymes that amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. Genkyotex is developing a pipeline

United statesBruxelles capitaleVictor thannickalUnited states national institutes of healthSerum instituteUniversity of alabama at birminghamDes marchEuronext parisEuronext brusselsKidney diseaseUnited states national institutesProfessor victor thannickalIndia private ltdஒன்றுபட்டது மாநிலங்களில்ப்ரூக்ஸெல்ஸ் தலைநகரம்ஒன்றுபட்டது மாநிலங்களில் தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம்